Pairing smoking-cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco

Cancer

Volumn 122, Issue 8, 2016, Pages 1150-1159

  Fucito, Lisa M ^a,b,c   Czabafy, Sharon ^d   Hendricks, Peter S ^e   Kotsen, Chris ^f   Richardson, Donna ^g   Toll, Benjamin A ^a,h,i  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Smilow Cancer Hospital at Yale New Haven   (United States)

^c YALE CANCER CENTER   (United States)

^d Wellspan Ephrata Community Hospital Wellness Center   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL   (United States)

^g ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^h MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

ⁱ MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

cigarette smoking; lung cancer screening prevention; smoking cessation; tobacco

Indexed keywords

AGE DISTRIBUTION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; HEALTH CARE ACCESS; HIGH RISK PATIENT; HUMAN; LIFE EXPECTANCY; LUNG CANCER; MOTIVATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SELF CONCEPT; SMOKING; SMOKING CESSATION; SURVIVAL TIME; TREATMENT DURATION; ADVERSE EFFECTS; ADVISORY COMMITTEE; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; ECONOMICS; EVIDENCE BASED MEDICINE; FEMALE; LUNG NEOPLASMS; MALE; MEDICAID; MEDICARE; ORGANIZATION AND MANAGEMENT; PROCEDURES; PROGRAM EVALUATION; TOBACCO USE DISORDER; UNITED STATES; X-RAY COMPUTED TOMOGRAPHY;

ADVISORY COMMITTEES; EARLY DETECTION OF CANCER; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MEDICAID; MEDICARE; PRACTICE GUIDELINES AS TOPIC; PROGRAM EVALUATION; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 84960981953     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29926     Document Type: Review

References (78)

1. Bach PB, Mirkin JN, Oliver TK, et al., Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012; 307: 2418-2429.
2. Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB,. Screening for lung cancer: diagnosis and management of lung cancer, 3rd edition: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143 (5 suppl): e78S-e92S.
3. Jaklitsch MT, Jacobson FL, Austin JH, et al., The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg. 2012; 144: 33-38.
4. Wender R, Fontham ET, Barrera E Jr, et al., American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013; 63: 107-117.
5. National Comprehensive Cancer (NCCN). NCCN Clinical Practice Guidelines in Oncology: Lung Cancer Screening. Version 2. Fort Washington, PA: NCCN; 2014.
6. Field JK, Smith RA, Aberle DR, et al., International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol. 2012; 7: 10-19.
7. Alberg AJ, Ford JG, Samet JM, American College of Chest Physicians. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007; 132 (3 suppl): 29S-55S.
8. Centers for Disease Control and Prevention (CDC). What Are the Risk Factors for Lung Cancer? Available at: http://www.cdc.gov/cancer/lung/basic-info/risk-factors.htm. Accessed January 11, 2016.
9. Brawley OW, Glynn TJ, Khuri FR, Wender RC, Seffrin JR,. The first Surgeon General's report on smoking and health: the 50th anniversary. Ca Cancer J Clin. 2014; 64: 5-8.
10. National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 2014.
11. Agaku IT, King BA, Dube SR, Centers for Disease Control and Prevention. Current cigarette smoking among adults-United States, 2005-2012. MMWR Morb Mortal Wkly Rep. 2014; 63: 29-34.
12. Pesch B, Kendzia B, Gustavsson P, et al., Cigarette smoking and lung cancer-relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer. 2012; 131: 1210-1219.
13. Humphrey L, Deffebach M, Pappas M, et al., Screening for Lung Cancer: Systematic Review to Update the US Preventive Services Task Force Recommendation. Rockville, MD: Agency for Healthcare Research and Quality; 2013.
14. Humphrey LL, Deffebach M, Pappas M, et al., Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive Services Task Force recommendation. Ann Intern Med. 2013; 159: 411-420.
15. Aberle DR, Adams AM, Berg CD, et al., Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365: 395-409.
16. Centers for Medicare and Medicaid Services. Decision Memo for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) (CAG-00439N). Baltimore, MD: Centers for Medicare and Medicaid Services; 2014.
17. Ma J, Ward EM, Smith R, Jemal A,. Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer. 2013; 119: 1381-1385.
18. Fiore M, Jaen C, Baker T, et al., Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2008.
19. Gellert C, Schottker B, Brenner H,. Smoking and all-cause mortality in older people: systematic review and meta-analysis. Arch Intern Med. 2012; 172: 837-844.
20. Jha P, Ramasundarahettige C, Landsman V, et al., 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013; 368: 341-350.
21. Cataldo JK,. Smoking and aging. Clinical implications. Part I: health and consequence. J Gerontol Nurs. 2003; 29: 15-20.
22. Takashima N, Miura K, Hozawa A, et al., Cigarette smoking in middle age and a long-term risk of impaired activities of daily living: NIPPON DATA80. Nicotine Tob Res. 2010; 12: 944-949.
23. Mons U, Muezzinler A, Gellert C, et al., Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium [serial online]. BMJ. 2015; 350: h1551.
24. Holahan CK, Holahan CJ, North RJ, Hayes RB, Powers DA, Ockene JK,. Smoking status, physical health-related quality of life, and mortality in middle-aged and older women. Nicotine Tob Res. 2013; 15: 662-669.
25. Thun MJ, Carter BD, Feskanich D, et al., 50-year trends in smoking-related mortality in the United States. N Engl J Med. 2013; 368: 351-364.
26. Parsons A, Daley A, Begh R, Aveyard P,. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis [serial online]. BMJ. 2010; 340: b5569.
27. Tanner NT, Kanodra NM, Gebregziabher M, et al., The association between smoking abstinence and mortality in the National Lung Screening Trial [published online ahead of print October 25, 2015]. Am J Respir Crit Care Med. doi: 10.1164/rccm.201507-1420OC.
28. Sobus SL, Warren GW,. The biologic effects of cigarette smoke on cancer cells. Cancer. 2014; 120: 3617-3626.
29. Warren GW, Sobus S, Gritz ER,. The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support. Lancet Oncol. 2014; 15: e568-e580.
30. Hall SM, Humfleet GL, Gorecki JA, Munoz RF, Reus VI, Prochaska JJ,. Older versus younger treatment-seeking smokers: differences in smoking behavior, drug and alcohol use, and psychosocial and physical functioning. Nicotine Tob Res. 2008; 10: 463-470.
31. Centers for Disease Control and Prevention (CDC). Quitting smoking among adults-United States, 2001-2010. MMWR Morb Mortal Wkly Rep. 2011; 60: 1513-1519.
32. Kerr S, Watson H, Tolson D, Lough M, Brown M,. Smoking after the age of 65 years: a qualitative exploration of older current and former smokers' views on smoking, stopping smoking, and smoking cessation resources and services. Health Soc Care Community. 2006; 14: 572-582.
33. Shadel WG, Elliott MN, Haas AC, et al., Clinician advice to quit smoking among seniors. Prev Med. 2015; 70: 83-89.
34. Allen S,. Tobacco smoking in older people. Rev Clin Gerontol. 2009; 19: 185-192.
35. Centers for Disease Control and Prevention (CDC). Smoking-cessation advice from health-care providers-Canada, 2005. MMWR Morb Mortal Wkly Rep. 2007; 56: 708-712.
36. Ashraf H, Tonnesen P, Holst Pedersen J, Dirksen A, Thorsen H, Dossing M,. Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST). Thorax. 2009; 64: 388-392.
37. van der Aalst CM, van Klaveren RJ, van den Bergh KA, Willemsen MC, de Koning HJ,. The impact of a lung cancer computed tomography screening result on smoking abstinence. Eur Respir J. 2011; 37: 1466-1473.
38. Townsend CO, Clark MM, Jett JR, et al., Relation between smoking cessation and receiving results from 3 annual spiral chest computed tomography scans for lung carcinoma screening. Cancer. 2005; 103: 2154-2162.
39. Tammemagi MC, Church TR, Hocking WG, et al., Evaluation of the lung cancer risks at which to screen ever-and never-smokers: screening rules applied to the PLCO and NLST cohorts [serial online]. PLoS Med. 2014; 11: e1001764.
40. van der Aalst CM, van den Bergh KA, Willemsen MC, de Koning HJ, van Klaveren RJ,. Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial. Thorax. 2010; 65: 600-605.
41. Park E, Ostroff J, Rakowski W, et al., Risk perceptions among participants undergoing lung cancer screening: baseline results from the national lung screening trial. Ann Behav Med. 2009; 37: 268-279.
42. Hahn EJ, Rayens MK, Hopenhayn C, Christian WJ,. Perceived risk and interest in screening for lung cancer among current and former smokers. Res Nurs Health. 2006; 29: 359-370.
43. Taylor KL, Cox LS, Zincke N, Mehta L, McGuire C, Gelmann E,. Lung cancer screening as a teachable moment for smoking cessation. Lung Cancer. 2007; 56: 125-134.
44. Schnoll RA, Bradley P, Miller SM, Unger M, Babb J, Cornfield M,. Psychological issues related to the use of spiral CT for lung cancer early detection. Lung Cancer. 2003; 39: 315-325.
45. Land SR, Marcus PM,. Cancer screening and diagnosis: opportunities for smoking cessation intervention [comment]. J Clin Oncol. 2015; 33: 1631-1632.
46. van der Aalst CM, van Klaveren RJ, de Koning HJ,. Does participation to screening unintentionally influence lifestyle behaviour and thus lifestyle-related morbidity? Best Pract Res Clin Gastroenterol. 2010; 24: 465-478.
47. Ostroff JS, Buckshee N, Mancuso CA, Yankelevitz DF, Henschke CI,. Smoking cessation following CT screening for early detection of lung cancer. Prev Med. 2001; 33: 613-621.
48. Zeliadt SB, Heffner JL, Sayre G, et al., Attitudes and perceptions about smoking cessation in the context of lung cancer screening. JAMA Intern Med. 2015; 175: 1530-1537.
49. Slatore CG, Sullivan DR, Pappas M, Humphrey LL,. Patient-centered outcomes among lung cancer screening recipients with computed tomography: a systematic review. J Thorac Oncol. 2014; 9: 927-934.
50. Ashraf H, Saghir Z, Dirksen A, et al., Smoking habits in the randomised Danish Lung Cancer Screening Trial with low-dose CT: final results after a 5-year screening programme. Thorax. 2014; 69: 574-579.
51. Styn MA, Land SR, Perkins KA, Wilson DO, Romkes M, Weissfeld JL,. Smoking behavior 1 year after computed tomography screening for lung cancer: effect of physician referral for abnormal CT findings. Cancer Epidemiol Biomarkers Prev. 2009; 18: 3484-3489.
52. Cox LS, Clark MM, Jett JR, et al., Change in smoking status after spiral chest computed tomography scan screening. Cancer. 2003; 98: 2495-2501.
53. Anderson CM, Yip R, Henschke CI, Yankelevitz DF, Ostroff JS, Burns DM,. Smoking cessation and relapse during a lung cancer screening program. Cancer Epidemiol Biomarkers Prev. 2009; 18: 3476-3483.
54. Park ER, Gareen IF, Japuntich S, et al., Primary care provider-delivered smoking cessation interventions and smoking cessation among participants in the National Lung Screening Trial. JAMA Intern Med. 2015; 175: 1509-1516.
55. Poghosyan H, Kennedy Sheldon L, Cooley ME,. The impact of computed tomography screening for lung cancer on smoking behaviors: a teachable moment? Cancer Nurs. 2012; 35: 466-475.
56. van der Aalst CM, de Koning HJ, van den Bergh KA, Willemsen MC, van Klaveren RJ,. The effectiveness of a computer-tailored smoking cessation intervention for participants in lung cancer screening: a randomised controlled trial. Lung Cancer. 2012; 76: 204-210.
57. Ferketich AK, Otterson GA, King M, Hall N, Browning KK, Wewers ME,. A pilot test of a combined tobacco dependence treatment and lung cancer screening program. Lung Cancer. 2012; 76: 211-215.
58. Villanti AC, Jiang Y, Abrams DB, Pyenson BS,. A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions [serial online]. PLoS One. 2013; 8: e71379.
59. Clark MM, Cox LS, Jett JR, et al., Effectiveness of smoking cessation self-help materials in a lung cancer screening population. Lung Cancer. 2004; 44: 13-21.
60. Morgan GD, Noll EL, Orleans CT, Rimer BK, Amfoh K, Bonney G,. Reaching midlife and older smokers: tailored interventions for routine medical care. Prev Med. 1996; 25: 346-354.
61. Hanna N, Mulshine J, Wollins DS, Tyne C, Dresler C,. Tobacco cessation and control a decade later: American Society of Clinical Oncology policy statement update. J Clin Oncol. 2013; 31: 3147-3157.
62. National Comprehensive Cancer Network (NCCN). Smoking Cessation. Version 1.2015. NCCN Clinical Practice Guidelines in Oncology. Fort Washington, PA: NCCN; 2015.
63. American College of Chest Physicians. Tobacco Dependence Treatment Tool Kit: Help Your Patients Stop Smoking Today. Available at: http://tobaccodependence.chestnet.org/ on Accessed November 2, 2015.
64. Gordon JS, Andrews JA, Crews KM, Payne TJ, Severson HH,. The 5A's vs 3A's plus proactive quitline referral in private practice dental offices: preliminary results. Tob Control. 2007; 16: 285-288.
65. Richter KP, Ellerbeck EF,. It's time to change the default for tobacco treatment. Addiction. 2015; 110: 381-386.
66. Tang MW, Oakley R, Dale C, Purushotham A, Moller H, Gallagher JE,. A surgeon led smoking cessation intervention in a head and neck cancer centre [serial online]. BMC Health Serv Res. 2014; 14: 636.
67. Warren GW, Marshall JR, Cummings KM, et al., Automated tobacco assessment and cessation support for cancer patients. Cancer. 2014; 120: 562-569.
68. Carpenter MJ, Hughes JR, Solomon LJ, Callas PW,. Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. J Consult Clin Psychol. 2004; 72: 371-381.
69. Carpenter MJ, Hughes JR, Keely JP,. Effect of smoking reduction on later cessation: a pilot experimental study. Nicotine Tob Res. 2003; 5: 155-162.
70. Fucito LM, Bars MP, Forray A, et al., Writing Committee for the SRNT Policy and Treatment Networks. Addressing the evidence for FDA nicotine replacement therapy label changes: a policy statement of the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. Nicotine Tob Res. 2014; 16: 909-914.
71. Burris JL, Heckman BW, Mathew AR, Carpenter MJ,. A mechanistic test of nicotine replacement therapy sampling for smoking cessation induction. Psychol Addict Behav. 2015; 29: 392-399.
72. Jardin BF, Cropsey KL, Wahlquist AE, et al., Evaluating the effect of access to free medication to quit smoking: a clinical trial testing the role of motivation. Nicotine Tob Res. 2014; 16: 992-999.
73. Carpenter MJ, Hughes JR, Gray KM, Wahlquist AE, Saladin ME, Alberg AJ,. Nicotine therapy sampling to induce quit attempts among smokers unmotivated to quit: a randomized clinical trial. Arch Intern Med. 2011; 171: 1901-1907.
74. Asfar T, Ebbert JO, Klesges RC, Relyea GE,. Do smoking reduction interventions promote cessation in smokers not ready to quit? Addict Behav. 2011; 36: 764-768.
75. Donze J, Ruffieux C, Cornuz J,. Determinants of smoking and cessation in older women. Age Ageing. 2007; 36: 53-57.
76. Zbikowski SM, Magnusson B, Pockey JR, Tindle HA, Weaver KE,. A review of smoking cessation interventions for smokers aged 50 and older. Maturitas. 2012; 71: 131-141.
77. Brandon TH, Goniewicz ML, Hanna NH, et al., Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Res. and the American Society of Clinical Oncology. J Clin Oncol. 2015; 33: 952-963.
78. Cummings KM, Dresler CM, Field JK, et al., E-cigarettes and cancer patients. J Thorac Oncol. 2014; 9: 438-441.